Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,074
Total Claims
$1.4M
Drug Cost
821
Beneficiaries
$1,651
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-48%
Opioid rate vs peers
1.2% vs 2.2% avg
+17%
Cost per patient vs peers
$1,651 vs $1,411 avg
+47%
Brand preference vs peers
15.6% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.2%
Opioid Rate
105
Opioid Claims
$1,478
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,397 claims · $1.1M
Generic: 7,563 claims · $193K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 155 | $237K |
| Apixaban | 106 | $151K |
| Insulin Glargine,hum.Rec.Anlog | 41 | $63K |
| Dulaglutide | 17 | $48K |
| Rivaroxaban | 28 | $47K |
| Sitagliptin Phosphate | 31 | $47K |
| Mirabegron | 33 | $37K |
| Budesonide/Formoterol Fumarate | 42 | $37K |
| Empagliflozin | 32 | $35K |
| Insulin Glargine,hum.Rec.Anlog | 37 | $35K |
| Insulin Lispro | 29 | $34K |
| Linagliptin | 21 | $32K |
| Liraglutide | 12 | $28K |
| Tiotropium Bromide | 21 | $28K |
| Insulin Glargine,hum.Rec.Anlog | 14 | $25K |
Prescribing Profile
Patient Profile
76
Avg Age
54%
Female
1.15
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About